Subscribe
shutterstock_1086968018_jarretera-2
Jarretera / Shutterstock.com
17 June 2019Americas

FDA selects Merck, IBM, KPMG and Walmart for blockchain pilot

The US Food and Drug Administration (FDA) has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
IBM patent targets blockchain in open scientific research
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.
Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
IBM patent targets blockchain in open scientific research
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.
Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.

More on this story

Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
IBM patent targets blockchain in open scientific research
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.
Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?